BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23656358)

  • 1. Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era.
    Saliba F; Delvart V; Ichaï P; Kassis N; Botterel F; Mihaila L; Azoulay D; Adam R; Castaing D; Bretagne S; Samuel D
    Clin Transplant; 2013; 27(4):E454-61. PubMed ID: 23656358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretransplant model for end stage liver disease score predicts posttransplant incidence of fungal infections after liver transplantation.
    Lichtenstern C; Hochreiter M; Zehnter VD; Brenner T; Hofer S; Mieth M; Büchler MW; Martin E; Weigand MA; Schemmer P; Busch CJ
    Mycoses; 2013 May; 56(3):350-7. PubMed ID: 23346877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes associated with amphotericin B lipid complex (ABLC) prophylaxis in high-risk liver transplant patients.
    Saliba F; Delvart V; Ichaï P; Kassis N; Botterel F; Mihaila L; Azoulay D; Adam R; Castaing D; Bretagne S; Samuel D
    Med Mycol; 2013 Feb; 51(2):155-63. PubMed ID: 22800082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center.
    Agopian VG; Petrowsky H; Kaldas FM; Zarrinpar A; Farmer DG; Yersiz H; Holt C; Harlander-Locke M; Hong JC; Rana AR; Venick R; McDiarmid SV; Goldstein LI; Durazo F; Saab S; Han S; Xia V; Hiatt JR; Busuttil RW
    Ann Surg; 2013 Sep; 258(3):409-21. PubMed ID: 24022434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive fungal infections following liver transplantation: incidence, risk factors, survival, and impact of fluconazole-resistant Candida parapsilosis (2003-2007).
    Raghuram A; Restrepo A; Safadjou S; Cooley J; Orloff M; Hardy D; Butler S; Koval CE
    Liver Transpl; 2012 Sep; 18(9):1100-9. PubMed ID: 22577087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes after liver transplantation in patients achieving a model for end-stage liver disease score of 40 or higher.
    Alexopoulos S; Matsuoka L; Cho Y; Thomas E; Sheikh M; Stapfer M; Dhanireddy K; Sher L; Selby R; Genyk Y
    Transplantation; 2013 Feb; 95(3):507-12. PubMed ID: 23380865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
    Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
    Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Analysis for Invasive Fungal Infection after Living Donor Liver Transplantation: Which Patient Needs Potent Prophylaxis?
    Utsumi M; Umeda Y; Yagi T; Nagasaka T; Shinoura S; Yoshida R; Nobuoka D; Kuise T; Fuji T; Takagi K; Takaki A; Fujiwara T
    Dig Surg; 2019; 36(1):59-66. PubMed ID: 29649828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying a targeted population at high risk for infections after liver transplantation in the MELD era.
    Sun HY; Cacciarelli TV; Singh N
    Clin Transplant; 2011; 25(3):420-5. PubMed ID: 20482564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
    Taniguchi M
    Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious complications in the era of MELD.
    Juntermanns B; Manka P; Hoyer DP; Kaiser GM; Radunz S; Pracht W; Mathé Z; Rath PM; Steinmann J; Treckmann JW; Schulze M
    Ann Transplant; 2015 May; 20():297-302. PubMed ID: 26017072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation.
    Shi SH; Lu AW; Shen Y; Jia CK; Wang WL; Xie HY; Zhang M; Liang TB; Zheng SS
    Chin Med J (Engl); 2008 Apr; 121(7):625-30. PubMed ID: 18466683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model for end-stage liver disease score versus simplified acute physiology score criteria in acute renal failure after liver transplantation.
    Umbro I; Tinti F; Mordenti M; Rossi M; Ianni S; Pugliese F; Ruberto F; Ginanni Corradini S; Nofroni I; Poli L; Berloco PB; Mitterhofer AP
    Transplant Proc; 2011 May; 43(4):1139-41. PubMed ID: 21620072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive fungal infections in liver transplantation.
    Liu X; Ling Z; Li L; Ruan B
    Int J Infect Dis; 2011 May; 15(5):e298-304. PubMed ID: 21345708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients.
    Bailly S; Bouadma L; Azoulay E; Orgeas MG; Adrie C; Souweine B; Schwebel C; Maubon D; Hamidfar-Roy R; Darmon M; Wolff M; Cornet M; Timsit JF
    Am J Respir Crit Care Med; 2015 May; 191(10):1139-46. PubMed ID: 25780856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
    Croome KP; Marotta P; Wall WJ; Dale C; Levstik MA; Chandok N; Hernandez-Alejandro R
    Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of cirrhotic patients with blunt abdominal trauma: analysis of risk factor of postoperative death with the Model for End-Stage Liver Disease score.
    Lin BC; Fang JF; Wong YC; Hwang TL; Hsu YP
    Injury; 2012 Sep; 43(9):1457-61. PubMed ID: 21511254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High model for end-stage liver disease score as a predictor of survival during long-term follow-up after liver transplantation.
    Suzuki H; Bartlett AS; Muiesan P; Jassem W; Rela M; Heaton N
    Transplant Proc; 2012 Mar; 44(2):384-8. PubMed ID: 22410023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.